Table 1.
Patient baseline characteristics (n = 72)
| Variables | n (%), mean ± SD, or median (range) |
|---|---|
| Male | 56 (72.2%) |
| Age (years) | 54.9 ± 10.6 |
| Background liver diseasea | |
| CHB/child A cirrhosis/child B cirrhosis | 20 (27.7%)/44 (61.1%)/8 (11.2%) |
| Body mass index (kg/m2) | 24.0 ± 2.8 |
| White blood cell count (103/μl) | 5,740 (2,420–26,930) |
| Hemoglobin (g/dl) | 14.1 ± 1.5 |
| Platelet count (109/l) | 154.2 ± 72.8 |
| Total protein (mg/dl) | 7.0 ± 1.1 |
| Albumin (mg/dl) | 4.1 ± 0.7 |
| Total bilirubin (mg/dl) | 1.2 ± 0.6 |
| AST (IU/l) | 48.5 ± 49.3 |
| ALT (IU/l) | 49.3 ± 40.9 |
| Cholesterol (mg/dl) | 150.2 ± 32.2 |
| Gamma glutamyltranspeptidase (IU/l) | 63.4 ± 70.5 |
| Alkaline phosphatase (IU/l) | 95.6 ± 45.2 |
| Prothrombin time (%) | 90.0 ± 9.5 |
| Alpha-feto protein (ng/ml) | 15.5 (2.6–39,879.7) |
| <20 | 41 (56.9%) |
| <400 and ≥20 | 17 (23.6%) |
| ≥400 | 14 (19.5%) |
| Spleen size (cm) | 10.8 ± 2.29 |
| ICG R15 (%) | 11.8 ± 7.1 |
| Liver stiffness/IQR (kPa)/SR | 17.1 ± 11.2/1.7 ± 0.8/88.8% |
CHB, chronic hepatitis B; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ICG R15, indocyanine green retention at 15 min; IQR, interquartile range; SR, success rate
aBackground liver disease was defined after surgery